Unibest

Pharmaceutical intermediates

Apalutamide Intermediates

3 pharmaceutical intermediates for Apalutamide. Indication: Castration-resistant prostate cancer; Prostate cancer.

Submit a ProjectAll intermediates

About Apalutamide

Originator
Janssen Biotech Inc
Indication
Castration-resistant prostate cancer; Prostate cancer
Approved Date
02/14/2018
DS/DP
03/27/2027

Available intermediates

3 intermediates currently listed for Apalutamide. Request specifications, documentation or a quotation for any item below.

Apalutamide intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
5-Amino-3-(trifluoromethyl)picolinonitrile573762-62-6//
N-Boc-1-aminocyclobutanecarboxylic acid120728-10-1//
1-amino-N-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]Cyclobutanecarboxamide1950587-17-3//

Other programs under A

AbemaciclibAbrocitinibAcalabrutinibAdagrasibAfatinibAfoxolanerAlectinib HydrochlorideAlfacalcidol

Building toward Apalutamide?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →